An ever-increasing metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: what are problems and countermeasures?
Hepatobiliary Surg Nutr
.
2023 Dec 1;12(6):941-944.
doi: 10.21037/hbsn-23-538.
Epub 2023 Nov 9.
Authors
Shigeo Shimose
1
,
Tsubasa Tsutsumi
1
,
Dan Nakano
1
,
Tomoya Sano
1
,
Keisuke Amano
1
,
Takumi Kawaguchi
1
Affiliation
1
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
PMID:
38115921
PMCID:
PMC10727816
DOI:
10.21037/hbsn-23-538
No abstract available
Keywords:
Hepatoma; hepatic steatosis; lenvatinib (LEN); metabolic syndrome; viral hepatitis.
Publication types
Editorial
Comment